Genetic factors influencing age at onset in LRRK2-linked Parkinson disease

Yulia Golub, Daniela Berg, Donald B. Calne, Ronald F. Pfeiffer, Ryan J. Uitti, A. Jon Stoessl, Zbigniew K. Wszolek, Matthew J. Farrer, Jakob C. Mueller, Thomas Gasser, Julia Fuchs

Research output: Contribution to journalArticlepeer-review

29 Scopus citations

Abstract

Patients with Leucine-rich repeat kinase 2 (LRRK2) linked Parkinson's disease (PD) clinically present with typical idiopathic PD. However, LRRK2-linked PD displays a pleomorphic neuropathology and high variability in age at disease onset (AAO) which suggests that environmental and/or genetic factors other than the mutation itself influence the course of the disease. We investigated the modulation of AAO by genetic factors including the mutation-containing domain and PD associated polymorphisms in the gene coding alpha-synuclein (SNCA) and tau (MAPT) in 44 patients from 19 affected families. Using this limited number of available LRRK2 mutation carriers, we provide evidence that mutations in the kinase domain of Lrrk2 significantly decrease AAO compared to mutations in the ROC (Ras/GTPase of complex proteins) domain. Furthermore, polymorphic variations in MAPT show a significant association with AAO in individuals with LRRK2 mutations. Our results await replication in future studies with a larger number of LRRK2 mutation carriers, but indicate an association of mutation-affected protein domain and mutation-extrinsic genetic factors with AAO and suggest that these factors could contribute to explain the phenotypic heterogeneity observed in LRRK2-linked PD.

Original languageEnglish (US)
Pages (from-to)539-541
Number of pages3
JournalParkinsonism and Related Disorders
Volume15
Issue number7
DOIs
StatePublished - Aug 2009
Externally publishedYes

Keywords

  • AAO
  • LRRK2
  • MAPT
  • Parkinson's disease

ASJC Scopus subject areas

  • Neurology
  • Geriatrics and Gerontology
  • Clinical Neurology

Fingerprint

Dive into the research topics of 'Genetic factors influencing age at onset in LRRK2-linked Parkinson disease'. Together they form a unique fingerprint.

Cite this